These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3999928)

  • 21. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR; Bierman EL
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia).
    Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1970 Oct; 49(10):1853-8. PubMed ID: 5460288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia.
    Kashyap ML; Hynd BA; Robinson K; Gartside PS
    Metabolism; 1981 Feb; 30(2):111-8. PubMed ID: 7464559
    [No Abstract]   [Full Text] [Related]  

  • 25. Abnormal lipoprotein lipase in familial exogenous hypertriglyceridemia.
    Schreibman PH; Arons DL; Saudek CD; Arky RA
    J Clin Invest; 1973 Aug; 52(8):2075-82. PubMed ID: 4719678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retarded chylomicron apolipoprotein-B catabolism in type 2 (non-insulin-dependent) diabetic subjects with lipaemia.
    Haffner SM; Foster DM; Kushwaha RS; Hazzard WR
    Diabetologia; 1984 May; 26(5):349-54. PubMed ID: 6734981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III.
    Holdsworth G; Stocks J; Dodson P; Galton DJ
    J Clin Invest; 1982 Apr; 69(4):932-9. PubMed ID: 7076853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Test meals rich in marine long-chain n-3 polyunsaturated fatty acids increase postprandial chylomicron response.
    Griffo E; Di Marino L; Patti L; Bozzetto L; Annuzzi G; Cipriano P; Mangione A; Della Pepa G; Cocozza S; Riccardi G; Rivellese AA
    Nutr Res; 2014 Aug; 34(8):661-6. PubMed ID: 25193793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.
    Ghiselli G; Schaefer EJ; Zech LA; Gregg RE; Brewer HB
    J Clin Invest; 1982 Aug; 70(2):474-7. PubMed ID: 7096573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.
    Carlson LA; Holmquist L; Nilsson-Ehle P
    Acta Med Scand; 1986; 219(5):435-47. PubMed ID: 3739751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin A loading--an indicator of post-prandial lipoprotein clearance in healthy and hypertriglyceridemic subjects.
    Rassin T; Liron M; Rubinstein A; Arad J; Weintraub M
    Isr J Med Sci; 1992 Oct; 28(10):706-10. PubMed ID: 1399499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of triglyceride rich lipoproteins with very light density by ultracentrifugation and agarose gel electrophoresis using triglyceride- and cholesterol-staining.
    Hidaka H; Tozuka M; Meyer B; Yamauchi K; Sugano M; Nakabayashi T; Katsuyama T
    Ann Clin Lab Sci; 2003; 33(2):167-78. PubMed ID: 12817621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD; Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats.
    Mamo JC; Hirano T; Sainsbury A; Fitzgerald AK; Redgrave TG
    Biochim Biophys Acta; 1992 Oct; 1128(2-3):132-8. PubMed ID: 1420285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia.
    Otto C; Pschierer V; Soennichsen AC; Schwandt P; Richter WO
    Metabolism; 1997 Nov; 46(11):1299-304. PubMed ID: 9361689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.
    Breckenridge WC; Little JA; Steiner G; Chow A; Poapst M
    N Engl J Med; 1978 Jun; 298(23):1265-73. PubMed ID: 565877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of primary chylomicronemia due to familial hypertriglyceridemia by omega-3 fatty acids.
    Richter WO; Jacob BG; Ritter MM; Schwandt P
    Metabolism; 1992 Oct; 41(10):1100-5. PubMed ID: 1406295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
    Karpe F; Hellénius ML; Hamsten A
    Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.